Micafungin and a case of polymorphic ventricular tachycardia.

P J ShahV SundareshanB MillerScott J Bergman

Published in: Journal of clinical pharmacy and therapeutics (2016)

This is the first known case of polymorphic ventricular tachycardia with micafungin as the possible cause. Clinicians should be aware of this potential adverse event and monitor patients receiving concomitant drugs that can prolong QT interval.

Keyphrases

drug induced
palliative care
human health
adverse drug
climate change
electronic health record